Lymphoma: How do we treat it? Where are future therapies headed? On Wednesday, Dec. 18, Ann LaCasce, MD, of the Dana-Farber/Brigham and Women’s Cancer Center Adult Lymphoma Program will answer your questions about lymphoma care in a live video webchat. The 45-minute chat starts at 1 p.m. EST and will air live on Dana-Farber’s YouTube page. LaCasce will discuss current treatment options as well as future therapies for lymphoma. If you have a question for Dr. LaCasce, email email@example.com. You can also submit questions by sending us a Tweet @DanaFarber using the hashtag #DFCIWebchat. Bookmark the webchat video page and …
By Maggie Loucks, NP-C When I was diagnosed with breast cancer at age 28, during my last semester of graduate school, I remember thinking that this had to mean something. I needed to turn an unfortunate situation into something positive, so I decided to pursue oncology nursing where I felt I could make a difference.
When Tara Shuman was diagnosed with breast cancer in August 2012, blogging was not the first thing that came to mind. “I put together an email to my friends and family to tell them about my diagnosis, and I realized when writing the email that it was very therapeutic,” Shuman says.
By Julie Salinger, LICSW The holiday season is full of cheer, but it can also be stressful, especially for cancer patients and their family caregivers. In addition to the extra time spent on shopping, cooking, and socializing, family interactions may bring complex dynamics, old grievances, and varying expectations to the forefront. The pressure to be “festive” can make even the healthiest person weary. Here are some tips for patients and their families for an enjoyable holiday season.
Stem cell transplantation (sometimes called bone marrow transplants) is a treatment for certain forms of cancer, such as leukemia, lymphoma, and multiple myeloma, as well as other diseases. But before a patient can receive a transplant, stem cells must be collected from a donor (an allogeneic donation) or from the patient (an autologous transplant).
Current lymphoma therapies are a far cry from the mustard gas used more than 50 years ago. More treatment options, including ones that may be more effective and less toxic, are being studied in ongoing clinical trials. “Clinical trials really are the future of lymphoma treatment,” says Ann LaCasce, MD, a medical oncologist in the Adult Lymphoma Program at Dana-Farber/Brigham and Women’s Cancer Center.
One month after undergoing a mammogram live on “Good Morning America,” ABC reporter Amy Robach announced Monday she has been diagnosed with breast cancer and will undergo a double mastectomy later this week. At 40-years old, Robach is among a population of younger women with breast cancer. According to the American Cancer Society, about 5 percent of all breast cancer cases in the United States occur in women age 40 and younger.
By Tim Crowley This Veteran’s Day, Dana-Farber thanks our patients, survivors, families, and friends who have served or are serving in the armed forces, including survivors Stacey Carroll, Ben Groen, and Tim Crowley, who tells his story below. In June 2010, I was diagnosed with acute myeloid leukemia (AML), a fast-moving disease where too many immature white blood cells are present in the blood and bone marrow, after doctors found abnormalities in routine blood work for the Marines. My wife, Julie, and I were in shock. We had just celebrated Father’s Day with our two young children, Jack and Kate, …
Cancer treatments such as chemotherapy, radiation, and certain medications can take a toll on patients, with side effects such as nausea. Although you may experience a loss of appetite during treatment, it is important to find ways to give your body the nutrients it needs. Here are simple strategies to help you manage nausea.
More than 228,000 new cases of lung cancer will be diagnosed in the United States in 2013, according to the National Cancer Institute (NCI). With November marking Lung Cancer Awareness Month, Pasi A. Jänne, MD, PhD, director of Dana-Farber’s Lowe Center for Thoracic Oncology, answers some key questions about the disease: